ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,768.37
      0.97%
      US Tech 100
      19,673.60
      1.20%
      Dow Jones
      42,109.36
      0.75%
      Brent Oil
      76.125
      1.34%
      Bitcoin
      70,091.23
      3.35%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Anebulo Pharmaceuticals Inc (ANEB)

      7. Anebulo Pharmaceuticals Inc (ANEB) Financials

      Anebulo Pharmaceuticals Inc

      Anebulo Pharmaceuticals Inc (ANEB)

      NASDAQ
      1.87
      -0.02
      ( -1.06% )
      Updated: 11:22:52
      Delayed by 15 minutes

      Anebulo Pharmaceuticals Inc Financial Summary

      The current ANEB market cap is 48.5M. The company's latest EPS is USD -0.3163 and P/E is -6.01.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -2.49M-2.54M-2.76M-1.66M-1.34M
      Net Income -2.5M-2.48M-2.72M-1.65M-1.35M
      Year End June 29 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -174k-3.61M-6.83M-11.78M-8.31M
      Net Income -175k-38.46M-6.83M-11.73M-8.2M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 11.67M9.05M7.5M6M4.07M
      Total Liabilities 1.07M717k1.01M1.01M260k
      Total Equity 10.6M8.33M6.49M4.99M3.81M
      Year End June 29 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 3.03M21.65M15.58M11.67M4.07M
      Total Liabilities 224k242k513k1.07M260k
      Total Equity -171k21.41M15.07M10.6M3.81M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -9.68M-2.73M-4.54M-6.04M-8.09M
      Investing N/A N/A N/A N/A N/A
      Financing 6.38M N/A -62k-62k-62k
      Year End June 29 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -151k-4.87M-5.44M-9.68M-8.09M
      Investing N/A N/A N/A N/A N/A
      Financing 3.18M21.83M N/A 6.38M-62k

      Stats and Ratios

      Market Cap 48.5M
      Price to Earnings Ratio -6.01
      Price to Sales Ratio 0
      Price to Cash Ratio 15.93
      Price to Book Ratio 12.92
      Dividend Yield -

      Share Statistics

      Shares Outstanding 25.93M
      Average Volume (1 week) 2.36k
      Average Volume (1 Month) 3.88k
      52 Week Change -9.22%
      52 Week High 3.30
      52 Week Low 1.72
      Spread (Intraday) 0.1 (5.21%)

      Company Info

      Company Name Anebulo Pharmaceuticals Inc
      Address 838 walker road
      dover, delaware 19904
      Website https://www.anebulo.com
      Industry pharmaceutical preparations (2834)